Category Archives: Cardiac Surgery

This article was originally published here Dan Med J. Continue reading →

1. Good and Bad News in Obesity A sobering research letter in November reported that 1 in 3 young adults in the United States are obese. The pandemic intensified the importance of combating obesity, as the risk for severe COVID-19 has a linear relationship with body mass index. Continue reading →

December 16, 2021 Datascope/Getinge/Maquet has recalled the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pump (IABP) systems because of one death and 71 complaints reported about fluid leaks. Continue reading →

Children and youth will soon have shorter wait times for some surgeries thanks to a new partnership between the IWK Health Centre and Scotia Surgery. Starting in February, IWK surgeons and anesthesiologists will perform some less-complex procedures at Scotia Surgery in Dartmouth, with the clinics nurses. Continue reading →

Skip to main content A new clinical trial being led by the University of Birmingham and funded by the British Heart Foundation could help improve the recovery of children who undergo life-saving heart surgery. The 570,000 study will compare two ways of protecting the heart when children require open heart surgery to repair congenital heart defects, to find which is most effective. Congenital heart disease is a heart defect that develops in the womb before a baby is born Continue reading →

LAS VEGAS, Dec. Continue reading →

Doctors performed did a bypass surgery on the beating heart Published: Tue 14 Dec 2021, 8:30 PM Last updated: Wed 15 Dec 2021, 1:19 PM At 38, Jai Singh Yadav a non-smoker and a vegetarian was shocked when he heard that only 10 per cent of his heart was functioning. Continue reading →

BORDEAUX, France--(BUSINESS WIRE)--FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced further funding of 6 million bringing the Series B total to 21 million, giving FineHeart a cash runway until the end of 2023. This financing comes in addition to the 15 million raised in June 2021 with the pool of industrial and independent investors: Lauak Group, Doliam, FineHeart Founders' Holding which brought together international private investors, mainly from the cardiology sector and the European investment fund Verve Ventures. Continue reading →

Then lucky No. 7 came along Continue reading →

Heparin-Induced Thrombocytopenia (HIT) Treatment Market: Overview Heparin-induced thrombocytopenia (HIT) is one of the most common side effects of heparin therapy. A number of thrombotic conditions need heparin therapy to reduce the risk of thrombosis Continue reading →